DYNAGLIPT M (Metformin (500mg) + Teneligliptin (20mg))

Dynaglipt-M Tablet is formulated with a combination of two active ingredients aimed at managing elevated blood glucose levels in individuals diagnosed with type 2 diabetes mellitus. Effective blood sugar control is crucial in mitigating the risk of serious health issues associated with diabetes, such as nephropathy and vision impairment, and it may also lower the likelihood of cardiovascular events like heart attacks and strokes. This medication can be administered on its own or in conjunction with other antidiabetic therapies. For optimal results, it should be complemented by a balanced diet and consistent physical activity. The prescribed dosage will vary based on individual health status, current blood glucose levels, and any additional medications being taken. Taking this tablet with food may help alleviate gastrointestinal discomfort, such as nausea. Consistency in the timing of daily doses is beneficial for maximizing the medication’s effectiveness, and it is advisable to continue the treatment unless instructed otherwise by a healthcare provider. Maintaining adherence to a recommended lifestyle, including dietary and exercise guidelines, is vital in managing diabetes effectively. Awareness of the potential side effects, such as gastrointestinal disturbances and the risk of hypoglycemia when combined with other diabetes medications, is important for safe use. Prior to initiating treatment, it’s essential to disclose any history of kidney, liver, or heart issues, as well as alcohol consumption patterns, to your healthcare provider. Pregnant or breastfeeding individuals should seek medical advice before starting this medication. Regular assessments of kidney function and blood glucose levels are recommended throughout the treatment period.